The University of Texas MD Anderson Cancer Center
TMC Member Since 1942
The University of Texas MD Anderson Cancer Center, the first member institution of Texas Medical Center, is one of the world’s most respected centers devoted exclusively to cancer patient care, research, education and prevention.
Created in 1941 as part of The University of Texas System, MD Anderson is one of the nation’s original three comprehensive cancer centers designated by the National Cancer Act of 1971 and is one of 68 National Cancer Institute-designated comprehensive cancer centers today. Since 1944, about 940,000 patients have turned to MD Anderson for cancer care in the form of targeted therapies, surgery, chemotherapy, radiation and proton therapy, immunotherapy or combinations of these and other treatments.
U.S. News & World Report’s “Best Hospitals” survey ranked MD Anderson as the top hospital in the nation for cancer care in 2013. It has achieved this highest ranking 10 times in the past 12 years and has ranked as one of the top two hospitals for cancer care since the magazine began its annual survey in 1990.
Ronald DePinho, M.D.
President, The University of Texas MD Anderson Cancer Center
Ronald DePinho, M.D., internationally recognized for basic and translational research in cancer, aging and age-associated degenerative disorders, is the fourth full-time president of The University of Texas MD Anderson Cancer Center.
DePinho’s laboratory has produced an array of discoveries leading to better methods of early cancer detection, improved cancer patient care and new cancer drug development. A former member of the board of directors of the American Association for Cancer Research, DePinho has served on numerous advisory boards in public and private sectors, including co-chair of the National Cancer Institute’s Mouse Models of Human Cancer Consortium and the National Institutes of Health’s Cancer Genome Atlas Project.
He has authored more than 250 peer-reviewed articles for scientific journals, has contributed to more than 50 books, chapters and review articles and has launched the careers of dozens of basic and translational cancer scientists. He earned a bachelor’s degree in biological sciences in 1977 from Fordham University, where he graduated summa cum laude as class salutatorian. He received his medical degree with distinction in microbiology and immunology in 1981 from Albert Einstein College of Medicine.